Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

In vivo [64Cu]CuCl2 PET imaging reveals activity of Dextran-Catechin on tumor copper homeostasis.

Parmar A, Pascali G, Voli F, Lerra L, Yee E, Ahmed-Cox A, Kimpton K, Cirillo G, Arthur A, Zahra D, Rahardjo G, Liu GJ, Lengkeek N, Saletta F, Charil A, Kavallaris M, Vittorio O.

Theranostics. 2018 Nov 9;8(20):5645-5659. doi: 10.7150/thno.29840. eCollection 2018.

2.

Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.

Tsoli M, Wadham C, Pinese M, Failes T, Joshi S, Mould E, Yin JX, Gayevskiy V, Kumar A, Kaplan W, Ekert PG, Saletta F, Franshaw L, Liu J, Gifford A, Weber MA, Rodriguez M, Cohn RJ, Arndt G, Tyrrell V, Haber M, Trahair T, Marshall GM, McDonald K, Cowley MJ, Ziegler DS.

Cancer Biol Ther. 2018;19(12):1078-1087. doi: 10.1080/15384047.2018.1491498. Epub 2018 Oct 9.

3.

Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo.

Murray J, Valli E, Yu DMT, Truong AM, Gifford AJ, Eden GL, Gamble LD, Hanssen KM, Flemming CL, Tan A, Tivnan A, Allan S, Saletta F, Cheung L, Ruhle M, Schuetz JD, Henderson MJ, Byrne JA, Norris MD, Haber M, Fletcher JI.

Eur J Cancer. 2017 Sep;83:132-141. doi: 10.1016/j.ejca.2017.06.024. Epub 2017 Jul 20.

4.

Correction: N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion.

Lane DJ, Saletta F, Rahmanto YS, Kovacevic Z, Richardson DR.

PLoS One. 2016 Feb 25;11(2):e0149922. doi: 10.1371/journal.pone.0149922. eCollection 2016. No abstract available.

5.

Genetic causes of cancer predisposition in children and adolescents.

Saletta F, Dalla Pozza L, Byrne JA.

Transl Pediatr. 2015 Apr;4(2):67-75. doi: 10.3978/j.issn.2224-4336.2015.04.08. Review.

6.

Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.

Carter DR, Murray J, Cheung BB, Gamble L, Koach J, Tsang J, Sutton S, Kalla H, Syed S, Gifford AJ, Issaeva N, Biktasova A, Atmadibrata B, Sun Y, Sokolowski N, Ling D, Kim PY, Webber H, Clark A, Ruhle M, Liu B, Oberthuer A, Fischer M, Byrne J, Saletta F, Thwe le M, Purmal A, Haderski G, Burkhart C, Speleman F, De Preter K, Beckers A, Ziegler DS, Liu T, Gurova KV, Gudkov AV, Norris MD, Haber M, Marshall GM.

Sci Transl Med. 2015 Nov 4;7(312):312ra176. doi: 10.1126/scitranslmed.aab1803.

7.

Molecular profiling of childhood cancer: Biomarkers and novel therapies.

Saletta F, Wadham C, Ziegler DS, Marshall GM, Haber M, McCowage G, Norris MD, Byrne JA.

BBA Clin. 2014 Jun 28;1:59-77. doi: 10.1016/j.bbacli.2014.06.003. eCollection 2014 Jun. Review.

8.

Advances in paediatric cancer treatment.

Saletta F, Seng MS, Lau LM.

Transl Pediatr. 2014 Apr;3(2):156-82. doi: 10.3978/j.issn.2224-4336.2014.02.01. Review.

9.

N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.

Lane DJ, Saletta F, Suryo Rahmanto Y, Kovacevic Z, Richardson DR.

PLoS One. 2013;8(2):e57273. doi: 10.1371/journal.pone.0057273. Epub 2013 Feb 21. Erratum in: PLoS One. 2016;11(2):e0149922.

10.

Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia.

Whitnall M, Suryo Rahmanto Y, Huang ML, Saletta F, Lok HC, Gutiérrez L, Lázaro FJ, Fleming AJ, St Pierre TG, Mikhael MR, Ponka P, Richardson DR.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20590-5. doi: 10.1073/pnas.1215349109. Epub 2012 Nov 20.

11.

Iron chelators for the treatment of cancer.

Yu Y, Gutierrez E, Kovacevic Z, Saletta F, Obeidy P, Suryo Rahmanto Y, Richardson DR.

Curr Med Chem. 2012;19(17):2689-702. Review.

PMID:
22455580
12.

Iron chelation: deciphering novel molecular targets for cancer therapy. The tip of the iceberg of a web of iron-regulated molecules.

Saletta F, Kovacevic Z, Richardson DR.

Future Med Chem. 2011 Dec;3(16):1983-6. doi: 10.4155/fmc.11.154. Erratum in: Future Med Chem. 2012 Jan;4(1):124.

PMID:
22098348
13.

Cellular iron depletion and the mechanisms involved in the iron-dependent regulation of the growth arrest and DNA damage family of genes.

Saletta F, Suryo Rahmanto Y, Siafakas AR, Richardson DR.

J Biol Chem. 2011 Oct 14;286(41):35396-406. doi: 10.1074/jbc.M111.273060. Epub 2011 Aug 18.

14.

The translational regulator eIF3a: the tricky eIF3 subunit!

Saletta F, Suryo Rahmanto Y, Richardson DR.

Biochim Biophys Acta. 2010 Dec;1806(2):275-86. doi: 10.1016/j.bbcan.2010.07.005. Epub 2010 Jul 17. Review.

PMID:
20647036
15.

Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53.

Saletta F, Suryo Rahmanto Y, Noulsri E, Richardson DR.

Mol Pharmacol. 2010 Mar;77(3):443-58. doi: 10.1124/mol.109.061028. Epub 2009 Dec 18.

PMID:
20023006
16.

A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.

Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, Rosa F, Di Gregorio A, Polidoro S, Saletta F, Ioannidis JP, Matullo G.

J Natl Cancer Inst. 2009 Jan 7;101(1):24-36. doi: 10.1093/jnci/djn437. Epub 2008 Dec 30.

PMID:
19116388
17.

32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies.

Munnia A, Saletta F, Allione A, Piro S, Confortini M, Matullo G, Peluso M.

Mutagenesis. 2007 Nov;22(6):381-5. Epub 2007 Aug 22.

PMID:
17716983
18.

Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells.

Saletta F, Matullo G, Manuguerra M, Arena S, Bardelli A, Vineis P.

Cancer Res. 2007 Aug 1;67(15):7088-94.

19.

Proteome characterization of a human urothelial cell line resistant to the bladder carcinogen 4-aminobiphenyl.

Pastorelli R, Saletta F, Carpi D, Campagna R, dell'Osta C, Schiarea S, Vineis P, Airoldi L, Matullo G.

Proteome Sci. 2007 May 3;5:6.

20.

Expression of DNA repair and metabolic genes in response to a flavonoid-rich diet.

Guarrera S, Sacerdote C, Fiorini L, Marsala R, Polidoro S, Gamberini S, Saletta F, Malaveille C, Talaska G, Vineis P, Matullo G.

Br J Nutr. 2007 Sep;98(3):525-33. Epub 2007 Apr 20.

PMID:
17445347
21.

Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions.

Manuguerra M, Matullo G, Veglia F, Autrup H, Dunning AM, Garte S, Gormally E, Malaveille C, Guarrera S, Polidoro S, Saletta F, Peluso M, Airoldi L, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulos D, Kalandidi A, Palli D, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund E, Pera G, Martinez C, Amiano P, Barricarte A, Tormo MJ, Quiros JR, Berglund G, Janzon L, Jarvholm B, Day NE, Allen NE, Saracci R, Kaaks R, Ferrari P, Riboli E, Vineis P.

Carcinogenesis. 2007 Feb;28(2):414-22. Epub 2006 Sep 6.

PMID:
16956909
22.

XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.

Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G.

Am J Epidemiol. 2006 Aug 15;164(4):297-302. Epub 2006 May 17. Review.

PMID:
16707649
23.

Intermittent jaundice: the result of a prolapsed gastric tumor occluding the common bile duct.

Rukstinat GJ, Saletta FJ, Tuleja CW.

IMJ Ill Med J. 1970 Jun;137(6):595-7. No abstract available.

PMID:
4393112
24.

Unusual postoperative ventral hernia.

SALETTA FJ, RUKSTINAT GJ.

Ill Med J. 1953 Jan;103(1):50-2. No abstract available.

PMID:
13022039
25.

Tooth pick perforation of the ileum.

SALETTA FJ, RUKSTINAT GJ.

Ill Med J. 1948 May;93(5):276. No abstract available.

PMID:
18862304

Supplemental Content

Loading ...
Support Center